Clinical Trial: Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naive Patients With Chronic HBV Infection

U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT02981602) titled 'Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naive Patients With Chronic HBV Infection' on Dec. 1, 2016.

Brief Summary: To examine the safety and tolerability of IONIS-HBVRx administration to treatment-naive patients with chronic hepatitis B virus infection

Study Type: Interventional

Condition: Chronic Hepatitis B Atypical

Intervention: * Drug: IONIS-HBVRx

Ascending multiple doses of IONIS-HBVRx by subcutaneous (SC) injection

Other Name: ISIS 505358

* Drug: Placebo

Placebo

Recruitment Status: Completed

Sponsor: Ionis Pharmaceuticals, Inc.

Information provided by (Responsible Par...